MAI-400

N/A

Report date: 2022/10/25 14:55:47
NME

Base Information

Drug NameMAI-400
Drug Alias NameMAI-400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho guanine nucleotide exchange factor 4 inhibitorsAdenomatous polyposis coli protein inhibitorsWnt signalling pathway modulators
TargetsRho guanine nucleotide exchange factor 4Adenomatous polyposis coli protein
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Jiaotong University
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Jiaotong University
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A